Hamlet BioPharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Quotes for Hamlet BioPharma AB

Right Now

+/-
0.35
%
9,33%
Latest
4.1
High
4.25
Low
3.61
Volume
281 309
Turnover (SEK)
1 114 363
Market Value (MSEK)
523,8
Time (Latest trade)
2024-06-14 15:02

Board

CEO

  • Martin Erixon (tf)

Chairperson of the Board

  • Catharina Svanborg

Board

  • Bill Hansson
  • Elisabeth Parker
  • Helena Lomberg
  • Magnus Nylen
  • Ulla Trädgårdh

Videos

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 36,31 76,26 2024-03-26
Avanza Pension 5,56 1,84 2024-03-26
Nordnet Pensionsförsäkring 4,75 1,51 2024-03-26
Rolf Karlsson 3,90 1,24 2024-03-26
Hans Nygren 1,93 0,61 2024-03-26
Gramsh Gashi 1,10 0,35 2024-03-26
Creative Invest One AB 0,77 0,25 2024-03-26
Swedbank Försäkring 0,76 0,24 2024-03-26
Försäkringsaktiebolaget Skandia 0,75 0,24 2024-03-26
Creative Networks X AB 0,53 0,17 2024-03-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream